Latest market price
20.99
-0.40-1.87%
News
Down 1.9% — A Fistful Of Magnificent CEFs (seekingalpha.com).
Medium confidence
TA
Loading chart...
Snapshot
| Index | — | P/E | 11.41 | EPS (ttm) | 1.84 | Insider Own | 0.37% | Shs Outstand | 57.19M | Perf Week | 3.30% |
| Market Cap | 1.20B | Forward P/E | — | EPS next Y | — | Insider Trans | 0.12% | Shs Float | 57.19M | Perf Month | 6.01% |
| Enterprise Value | 1.20B | PEG | — | EPS next Q | — | Short Float | 0.05% | Perf Quarter | -6.04% | ||
| Income | 99.00M | P/S | 12.00 | EPS this Y | — | Short Ratio | 0.15 | Perf Half Y | 5.32% | ||
| Sales | 100.00M | P/B | 1.10 | EPS next Y | — | ROA | 8.99% | Short Interest | 28.92K | Perf YTD | 10.82% |
| Book/sh | 19.13 | P/C | — | EPS next 5Y | — | ROE | 9.16% | 52W High | 24.85 -15.53% | Perf Year | 7.31% |
| Cash/sh | 0.00 | P/FCF | — | EPS past 3/5Y | — -19.67% | ROIC | 9.00% | 52W Low | 17.14 22.46% | Perf 3Y | 43.87% |
| Dividend Est. | 2.64 (12.58%) | EV/EBITDA | 12.13 | Sales past 3/5Y | 132.08% 61.86% | Gross Margin | — | Volatility | 2.94% 2.89% | Perf 5Y | -20.01% |
| Dividend TTM | 2.47 (11.77%) | EV/Sales | 12.00 | EPS Y/Y TTM | — | Oper. Margin | 98.80% | ATR (14) | 0.58 | Perf 10Y | -4.59% |
| Dividend Ex-Date | Aug 24, 2026 | Quick Ratio | 2.15 | Sales Y/Y TTM | — | Profit Margin | 98.80% | RSI (14) | 55.74 | Recom | — |
| Dividend Gr. 3/5Y | 8.60% 2.88% | Current Ratio | 2.15 | EPS Q/Q | — | SMA20 | 4.88% | Beta | 0.73 | Target Price | — |
| Payout | 0.00% | Debt/Eq | 0.00 | Sales Q/Q | 240.00% | SMA50 | -0.66% | Rel Volume | 0.93 | Prev Close | 21.39 |
| Employees | — | LT Debt/Eq | 0.00 | Earnings | — | SMA200 | 3.30% | Avg Volume | 178.69K | Price | 20.99 |
| IPO Date | Apr 23, 1987 | Option/Short | Yes / Yes | EPS/Sales Surpr. | — | Net Debt/EBITDA | 0.00 | Volume | 165,690 | Change | -1.87% |
Latest News· Times ET
Nov-02-26
07:35AM
Diversify Your Income By Hiring Specialistsseekingalpha.com
04:52AM
Oct-01-26
Oct-01-2604:01AM
Sep-30-26
Sep-30-2604:17PM
Sep-19-26
Sep-18-26
Aug-22-26
Aug-07-26
Aug-07-2605:58PM
Aug-03-26
Jul-20-26
Company
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | FY 2017 12/31/2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 100 | 11 | 10 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 0 | 0 | 0 | — | — | — | — | — | — | |
| Gross Profit | 100 | 11 | 10 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 1 | 11 | 11 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 0 | 0 | 0 | — | — | — | — | — | — | |
| Operating Income | 99 | 0 | -1 | — | — | — | — | — | — | |
| Interest Expense | 0 | 0 | 0 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 0 | 185 | 58 | — | — | — | — | — | — | |
| Net Income Before Taxes | 99 | 185 | 56 | — | — | — | — | — | — | |
| Income Taxes | 0 | 0 | 0 | — | — | — | — | — | — | |
| Consolidated Net Income | 99 | 185 | 56 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 99 | 185 | 56 | — | — | — | — | — | — | |
| Net Income | 99 | 185 | 56 | — | — | — | — | — | — | |
| EPS (Recurring) | 1.84 | 3.55 | 1.14 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.84 | 3.55 | 1.14 | — | — | — | — | — | — | |
| EPS (Diluted) | 1.84 | 3.55 | 1.14 | — | — | — | — | — | — | |
| EBITDA | 99 | 0 | 0 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 10.29 | 4.52 | 14.54 | — | — | — | — | — | — | |
| Price To Sales Ratio | 10.23 | 75.87 | 81.19 | — | — | — | — | — | — | |
| Gross Margin | 100.00 | 100.00 | 100.00 | — | — | — | — | — | — | |
| Operating Margin | 99.00 | 0.00 | -10.00 | — | — | — | — | — | — | |
| Net Margin | 99.00 | 1,681.82 | 560.00 | — | — | — | — | — | — | |
| Shares Outstanding | 54 | 52 | 49 | — | — | — | — | — | — | |
| Market Capitalization | 1,023 | 835 | 812 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Goodson Alan R | Director | Oct 06 '26 | Sale | 19.32 | 242 | 4,675 | 0 | Oct 07 |
| Mahai Chris LaVictoire | Director | Jul 16 '26 | Buy | 20.96 | 501 | 10,501 | 501 | Jul 20 |
| DiMartino Rose | Director | Jul 16 '24 | Buy | 18.88 | 1,000 | 18,880 | 1,000 | Jul 18 |
| Goetz Kathleen | Director | Apr 09 '24 | Buy | 16.42 | 525 | 8,622 | 1,080 | Apr 12 |
| Goodson Alan R | Vice President | Dec 21 '23 | Buy | 16.13 | 170 | 2,742 | 170 | Jan 09 |
| Reit Todd | Director | Jan 02 '24 | Buy | 16.93 | 1,000 | 16,929 | 1,000 | Jan 04 |
| Maher Bill | Director | Dec 28 '23 | Buy | 16.58 | 1,000 | 16,580 | 1,000 | Jan 02 |
| OMSTEAD DANIEL R | President | Sep 25 '23 | Buy | 15.63 | 9,500 | 148,515 | 178,269 | Sep 25 |
| OMSTEAD DANIEL R | President | Sep 20 '23 | Buy | 15.88 | 9,500 | 150,829 | 168,769 | Sep 20 |
| Goetz Kathleen | Director | Mar 23 '22 | Buy | 20.42 | 74 | 1,501 | 555 | Mar 24 |
| Goetz Kathleen | Director | Jan 26 '22 | Buy | 21.52 | 481 | 10,349 | 481 | Jan 27 |
| OMSTEAD DANIEL R | President | Oct 26 '20 | Buy | 20.53 | 5,200 | 106,744 | 125,411 | Oct 26 |
| OMSTEAD DANIEL R | President | Oct 21 '20 | Buy | 20.68 | 5,050 | 104,427 | 120,211 | Oct 21 |
| Bailey Jeffrey Allen | Director | Sep 23 '20 | Buy | 20.39 | 490 | 9,991 | 490 | Sep 23 |
| OMSTEAD DANIEL R | President | May 21 '20 | Buy | 21.01 | 5,000 | 105,054 | 110,357 | May 22 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.